Influence of combinations of bacteria on the levels of prostoglandin E2, interleukin-1β, and granulocyte elastase in gingival crevicular fluid and on the severity of periodontal disease

Journal of Periodontology

Volumn 77, Issue 6, 2006, Pages 1025-1031

  Airila Månsson, Stella ^a   Söder, Birgitta ^a   Kari, Kirsti ^b,c   Meurman, Jukka H ^b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Bacteria; Elastase; Inflammation mediators; Interleukin 1 beta; Periodontitis; Prostaglandin E2

Indexed keywords

ELASTASE; INTERLEUKIN 1BETA; MONOCLONAL ANTIBODY; PROSTAGLANDIN E2; INTERLEUKIN 1; LEUKOCYTE ELASTASE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADULT; ANALYSIS OF VARIANCE; ARTICLE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GINGIVITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MOUTH EXAMINATION; PERIODONTAL DISEASE; POLYMERASE CHAIN REACTION; PORPHYROMONAS GINGIVALIS; PREVOTELLA NIGRESCENS; PROSTAGLANDIN RELEASE; RADIOIMMUNOASSAY; TANNERELLA FORSYTHENSIS; TOOTH PLAQUE; TOOTH RADIOGRAPHY; CHEMISTRY; EPIDEMIOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY;

ADULT; DINOPROSTONE; EPIDEMIOLOGIC METHODS; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; INTERLEUKIN-1; LEUKOCYTE ELASTASE; MALE; PERIODONTAL DISEASES; PORPHYROMONAS GINGIVALIS; PREVOTELLA NIGRESCENS;

EID: 33747045865     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2006.050208     Document Type: Article

References (42)

1. Ximenez-Fyvie LA, Haffajee AD, Socransky SS. Comparison of the microbiota of supra- and subgingival plaque in health and periodontitis. J Clin Periodontol 2000;27:648-657.
2. Holt SC, Ebersole JL. Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: The "red complex," a prototype polybacterial pathogenic consortium in periodontitis. Periodontol 2000 2005;38:72-122.
3. Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontol 2000 2005;38:135-187.
4. Yoshimura A, Hara Y, Kaneko T, Kato I. Secretion of IL-1 beta, TNF-alpha, IL-8 and IL-1ra by human polymorphonuclear leukocytes in response to lipopolysaccharides from periodontopathic bacteria. J Periodontal Res 1997;32:279-286.
5. Hassell TM. Tissues and cells of the periodontium. Periodontol 2000 1993;3:9-38.
6. Michalowicz BS, Diehl SR, Gunsolley JC, et al. Evidence of a substantial genetic basis for risk of adult periodontitis. J Periodontol 2000;71:1699-1707.
7. 2 levels as a predictor of periodontal attachment loss. J Periodontal Res 1986;21:101-112.
8. Ratkay LG, Waterfield JD, Tonzetich J. Stimulation of enzyme and cytokine production by methyl mercaptan in human gingival fibroblast and monocyte cell cultures. Arch Oral Biol 1995;40:337-344.
9. Tomasinsig L, Scocchi M, Di Loreto C, Artico D, Zanetti M. Inducible expression of an antimicrobial peptide of the innate immunity in polymorphonuclear leukocytes. J Leukoc Biol 2002;72:1003-1010.
10. Zasloff M. Innate immunity, antimicrobial peptides, and protection of the oral cavity. Lancet 2002;360:1116-1117.
11. Tjabringa GS, Vos JB, Olthuis D, et al. Host defense effector molecules in mucosal secretions. FEMS Immunol Med Microbiol 2005;45:151-158.
12. Genco RJ. Current view of risk factors for periodontal diseases. J Periodontol 1996;67:(Suppl.)1041-1049.
13. Grossi SG, Zambon JJ, Ho AW, et al. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 1994;65:260-267.
14. 2 secretion as a determinant of periodontal disease expression. J Periodontol 1993;64: 432-444.
15. Teng YT, Nguyen H, Gao X, et al. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest 2000;106:R59-R67.
16. Takayanagi H. Inflammatory bone destruction and osteoimmunology. J Periodontal Res 2005;40:287-293.
17. Arakawa S, Nakajima T, Ishikura H, Ichinose S, Ishikawa I, Tsuchida N. Novel apoptosis-inducing activity in Bacteroides forsythus: A comparative study with three serotypes of Actinobacillus; actinomycetemcomitans. Infect Immun 2000;68:4611-4615.
18. Kornman KS, Crane A, Wang HY, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997;24:72-77.
19. Haffajee AD, Socransky SS. Relationship of cigarette smoking to the subgingival microbiota. J Clin Periodontol 2001;28:377-388.
20. Söder B, Jin LJ, Söder P-Ö, Wikner S. Clinical characteristics of destructive periodontitis in a risk group of Swedish urban adults. Swed Dent J 1995;19: 9-15.
21. Söder B, Jin LJ, Wickholm S. Granulocyte elastase, matrix metalloproteinase-8 and prostaglandin E2 in gingival crevicular fluid in matched clinical sites in smokers and non-smokers with persistent periodontitis. J Clin Periodontol 2002;29:384-391.
22. Söder P-Ö, Jin LJ, Söder B, Wikner S. Periodontal status in an urban adult population in Sweden. Community Dent Oral Epidemiol 1994;22:106-111.
23. Zambon JJ, Grossi SG, Machtei EE, Ho AW, Dunford R, Genco RJ. Cigarette smoking increases the risk for subgingival infection with periodontal pathogens. J Periodontol 1996;67:(Suppl.)1050-1054.
24. Söder B, Nedlich U, Jin LJ. Longitudinal effect of non-surgical treatment and systemic metronidazole for 1 week in smokers and non-smokers with refractory periodontitis: A 5-year study. J Periodontol 1999;70: 761-771.
25. Silness J, Löe H. Periodontal disease in pregnancy. II: Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
26. Löe H, Silness J. Periodontal disease in pregnancy. (I). Prevalence and severity. Acta Odontol Scand 1963;21: 533-551.
27. Jin LJ, Sbder PO, Åsman B, Söder B, Puriene A, Bergström K. Variations in crevicular fluid elastase levels in periodontitis patients on long-term maintenance. Eur J Oral Sci 1995;103:84-89.
28. Wouters FR, Salonen LE, Hellden LB, Frithiof L. Prevalence of interproximal periodontal intrabony defects in an adult population in Sweden. A radiographic study. J Clin Periodontol 1989;16:144-149.
29. Jin LJ, Soder PO, Asman B, Bergstrom K. Granulocyte elastase in gingival crevicular fluid: Improved monitoring of the site-specific response to treatment in patients with destructive periodontitis. J Clin Periodontol 1995;22:240-246.
30. Meurman JH, Wahlfors J, Korhonen A, et al. Identification of Bacteroides forsythus in subgingival dental plaque with the aid of a rapid PCR method. J Dent Res 1997;76:1376-1380.
31. Wahlfors J, Meurman JH, Vaisanen P, et al. Simultaneous detection of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis by a rapid PCR method. J Dent Res 1995;74:1796-1801.
32. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 1993;64: 474-484.
33. Williams RC. Periodontal disease. N Engl J Med 1990; 322:373-382.
34. Kaewsrichan J, Douglas CW, Nissen-Meyer J, Fimland G, Teanpaisan R. Characterization of a bacteriocin produced by Prevotella nigrescens ATCC 25261. Lett Appl Microbiol 2004;39:451-458.
35. Haffajee AD, Japlit M, Bogren A, Kent RL Jr., Goodson JM, Socransky SS. Differences in the subgingival microbiota of Swedish and USA subjects who were periodontally healthy or exhibited minimal periodontal disease. J Clin Periodontol 2005;32:33-39.
36. Buduneli N, Baylas H, Buduneli E, Turkoglu O, Kose T, Dahlen G. Periodontal infections and pre-term low birth weight: A case-control study. J Clin Periodontol 2005;32:174-181.
37. Tanner A, Kent R, Maiden MF, Taubman MA. Clinical, microbiological and immunological profile of healthy, gingivitis and putative active periodontal subjects. J Periodontal Res 1996;31:195-204.
38. DeCarlo AA, Paramaesvaran M, Yun PL, Collyer C, Hunter N. Porphyrin-mediated binding to hemoglobin by the HA2 domain of cysteine proteinases (gingipains) and hemagglutinins from the periodontal pathogen Porphyromonas gingivalis. J Bacteriol 1999;181: 3784-3791.
39. Yun PL, Decarlo AA, Chapple CC, Collyer CA, Hunter N. Binding of Porphyrornonas gingivalis gingipains to human CD4(+) T cells preferentially down-regulates surface CD2 and CD4 with little affect on co-stimulatory molecule expression. Microb Pathog 2005;38:85-96.
40. Yun PL, Decarlo AA, Chapple CC, Hunter N. Functional implication of the hydrolysis of platelet endothelial cell adhesion molecule 1 (CD31) by gingipains of Porphyromonas gingivalis for the pathology of periodontal disease. Infect Immun 2005;73:1386-1398.
41. Miura M, Hamachi T, Fujise O, Maeda K. The prevalence and pathogenic differences of Porphyromonas gingivalis fimA genotypes in patients with aggressive periodontitis. J Periodontal Res 2005;40: 147-152.
42. Kawada M, Yoshida A, Suzuki N, et al. Prevalence of Porphyromonas gingivalis in relation to periodontal status assessed by real-time PCR. Oral Microbiol Immunol 2004;19:289-292.